Glyco-engineering in plants to produce human-like N-glycan structures

Biotechnology Journal

Volumn 7, Issue 9, 2012, Pages 1088-1098

  Castilho, Alexandra ^a   Steinkellner, Herta ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Glyco engineering; Glycobiotechnology; N Glycosylation; Plant biotechnology; Recombinant proteins

Indexed keywords

BIOPHARMACEUTICAL INDUSTRY; COMPREHENSIVE ANALYSIS; DEGREE OF TOLERANCE; ENGINEERING EXPRESSION; GLYCO-ENGINEERING; GLYCOBIOTECHNOLOGY; GLYCOSYLATED PRODUCTS; HUMAN PROTEINS; N-GLYCAN STRUCTURES; N-GLYCOSYLATION; PLANT BIOTECHNOLOGY; POST-TRANSLATIONAL MODIFICATIONS;

ESTERIFICATION; GLYCOSYLATION; RECOMBINANT PROTEINS;

ENGINEERING;

GLYCAN; IMIGLUCERASE; MONOCLONAL ANTIBODY; OLIGOSACCHARIDE; RECOMBINANT ENZYME; RECOMBINANT PROTEIN; TALIGLUCERASE ALFA; TRANSFERRIN;

ANTIVIRAL ACTIVITY; ARABIDOPSIS; BIOSYNTHESIS; CELL VACUOLE; CLINICAL TRIAL (TOPIC); CYANOCOBALAMIN DEFICIENCY; DENTAL CARIES; ENDOPLASMIC RETICULUM; FUCOSYLATION; GAUCHER DISEASE; GENE TARGETING; GLYCOSYLATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAMMAL CELL; NICOTIANA BENTHAMIANA; NONHUMAN; PLANT BIOTECHNOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; REVIEW; SIALYLATION;

BIOTECHNOLOGY; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; METABOLIC ENGINEERING; PLANTS; RECOMBINANT PROTEINS;

EID: 84866037634     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201200032     Document Type: Review

References (82)

1. Apweiler, R., Hermjakob, H., Sharon, N., On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1999, 1473, 4-8.
2. Cummings, R. D., The repertoire of glycan determinants in the human glycome. Mol. Biosyst. 2009, 5, 1087-1104.
3. Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., Dwek, R. A., The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins. Ann. Rev. Immunol. 2007, 25, 21-50.
4. Jefferis, R., Glycosylation as a strategy to improve antibody-based therapeutics. Nat. Rev. Drug Discov. 2009, 8, 226-234.
5. Kaneko, Y., Nimmerjahn, F., Ravetch, J. V., Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation. Science 2006, 313, 670-673.
6. Aggarwal, S., What's fueling the biotech engine-2010 to 2011. Nat. Biotechnol. 2011, 29, 1083-1089.
7. Nelson, A. L., Dhimolea, E., Reichert, J. M., Development trends for human monoclonal antibody therapeutics. Nat. Rev. Drug Discov. 2010, 9, 767-774.
8. Stadlmann, J., Pabst, M., Kolarich, D., Kunert, R., Altmann, F., Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides. Proteomics 2008, 8, 2858-2871.
9. Van Patten, S. M., Hughes, H., Huff, M. R., Piepenhagen, P. A. et al., Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease. Glycobiology 2007, 17, 467-478.
10. Burrow, T. A., Grabowski, G. A., Velaglucerase alfa in the treatment of Gaucher disease type 1. Clin. Invest. 2011, 1, 285-293.
11. Takeuchi, M., Inoue, N., Strickland, T. W., Kubota, M. et al., Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA 1989, 86, 7819-7822.
12. Davis, J. M., Arakawa, T., Strickland, T. W., Yphantis, D. A., Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells. Biochemistry 1987, 26, 2633-2638.
13. Schachter, H., Biosynthetic Controls That Determine the Branching and Microheterogeneity of Protein-Bound Oligosaccharides. Biochem. Cell Biol. 1986, 64, 163-181.
14. Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N. et al., Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG fc. Science 2008, 320, 373-376.
15. Chung, C. H., Mirakhur, B., Chan, E., Le, Q. T. et al., Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1, 3-galactose. N. Engl. J. Med. 2008, 358, 1109-1117.
16. Jacobs, P. P., Callewaert, N., N-glycosylation engineering of biopharmaceutical expression systems. Curr. Mol. Med. 2009, 9, 774-800.
17. Walsh, G., Biopharmaceutical benchmarks 2010. Nat. Biotechnol. 2010, 28, 917-924.
18. D'Aoust, M. A., Couture, M. M., Charland, N., Trepanier, S. et al., The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol. J. 2010, 8, 607-619.
19. Sainsbury, F., Thuenemann, E. C., Lomonossoff, G. P., pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants. Plant Biotechnol. J. 2009, 7, 682-693.
20. Pogue, G. P., Vojdani, F., Palmer, K. E., Hiatt, E. et al., Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems. Plant Biotechnol. J. 2010, 8, 638-654.
21. Gleba, Y., Giritch, A., Vaccines, antibodies and pharmaceuticals. in: Altman, A., Hasegawa, P.M. (Ed), Plant Biotechnology and Agriculture, Elsevier Inc, 2012, pp 465-479.
22. Fitchette-Laine, A. C., Gomord, V., Cabanes, M., Michalski, J. C. et al., N-glycans harboring the Lewis a epitope are expressed at the surface of plant cells. Plant J. 1997, 12, 1411-1417.
23. Strasser, R., Bondili, J. S., Vavra, U., Schoberer, J. et al., A unique beta1, 3-galactosyltransferase is indispensable for the biosynthesis of N-glycans containing Lewis a structures in Arabidopsis thaliana. Plant Cell 2007, 19, 2278-2292.
24. Betenbaugh, M. J., Tomiya, N., Narang, S., Hsu, J. T. A., Lee, Y. C., Biosynthesis of human-type N-glycans in heterologous systems. Curr. Opin. Struct. Biol. 2004, 14, 601-606.
25. Liebminger, E., Veit, C., Pabst, M., Batoux, M. et al., Beta-N-acetylhexosaminidases HEXO1 and HEXO3 are responsible for the formation of paucimannosidic N-glycans in Arabidopsis thaliana. J. Biol. Chem. 2011, 286, 10793-10802.
26. Strasser, R., Stadlmann, J., Schahs, M., Stiegler, G. et al., Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol. J. 2008, 6, 392-402.
27. Castilho, A., Bohorova, N., Grass, J., Bohorov, O. et al., Rapid high yield production of different glycoforms of Ebola virus monoclonal antibody. PLoS One 2011, 6, e26040.
28. Dirnberger, D., Steinkellner, H., Abdennebi, L., Remy, J. J., van de Wiel, D., Secretion of biologically active glycoforms of bovine follicle stimulating hormone in plants. Eur. J. Biochem. 2001, 268, 4570-4579.
29. van Ree, R., Cabanes-Macheteau, M., Akkerdaas, J., Milazzo, J. P. et al., Beta(1, 2)-xylose and alpha(1, 3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens. Biol Chem 2000, 275, 11451-11458.
30. Jin, C., Altmann, F., Strasser, R., Mach, L. et al., A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits. Glycobiology 2008, 18, 235-241.
31. Altmann, F., The role of protein glycosylation in allergy. Int. Arch. Allergy Appl. Immunol. 2007, 142, 99-115.
32. Manduzio, H., Fitchette, A. C., Hrabina, M., Chabre, H. et al., Glycoproteins are species-specific markers and major IgE reactants in grass pollens. Plant Biotechnol. J. 2012, 10, 184-194.
33. Nagels, B., Weterings, K., Callewaert, N., Van Damme, E. J.M., Production of plant made pharmaceuticals: from plant host to functional protein. Crit. Rev. Plant Sci. 2012, 31, 148-180.
34. Loos, A., Steinkellner, H., IgG-Fc glycoengineering in non-mammalian expression hosts. Arch. Biochem. Biophys. 2012, in press, DOI: 10.1016/j.abb.2012.05.011.
35. Floss, D. M., Sack, M., Stadlmann, J., Rademacher, T. et al., Biochemical and functional characterization of anti-HIV antibody-ELP fusion proteins from transgenic plants. Plant Biotechnol. J. 2008, 6, 379-391.
36. Ko, K., Tekoah, Y., Rudd, P. M., Harvey, D. J. et al., Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc. Natl. Acad. Sci. USA 2003, 100, 8013-8018.
37. Schouten, A., Roosien, J., vanEngelen, F. A., deJong, G. A. M. et al., The C-terminal KDEL sequence increases the expression level of a single-chain antibody designed to be targeted to both the cytosol and the secretory pathway in transgenic tobacco. Plant Mol. Biol 1996, 30, 781-793.
38. Foresti, O., Denecke, J., Intermediate organelles of the plant secretory pathway: Identity and function. Traffic 2008, 9, 1599-1612.
39. Sonnewald, U., Brauer, M., von Schaewen, A., Stitt, M., Willmitzer, L., Transgenic tobacco plants expressing yeast-derived invertase in either the cytosol, vacuole or apoplast: a powerful tool for studying sucrose metabolism and sink/source interactions. Plant J. 1991, 1, 95-106.
40. Lerouge, P., Cabanes-Macheteau, M., Rayon, C., Fischette-Lainé, A.-C. et al., N-Glycoprotein biosynthesis in plants: recent developments and future trends. Plant Mol. Biol. 1998, 38, 31-48.
41. Shaaltiel, Y., Bartfeld, D., Hashmueli, S., Baum, G. et al., Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system. Plant Biotechnol. J. 2007, 5, 579-590.
42. Strasser, R., Altmann, F., Mach, L., Glossl, J., Steinkellner, H., Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1, 2-linked xylose and core alpha1, 3-linked fucose. FEBS Lett. 2004, 561, 132-136.
43. Schahs, M., Strasser, R., Stadlmann, J., Kunert, R. et al., Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol. J. 2007, 5, 657-663.
44. Loos, A., Van Droogenbroeck, B., Hillmer, S., Grass, J. et al., Expression of antibody fragments with a controlled N-glycosylation pattern and induction of endoplasmic reticulum-derived vesicles in seeds of Arabidopsis. Plant Physiol. 2011, 155, 2036-2048.
45. De Jaeger, G., Scheffer, S., Jacobs, A., Zambre, M. et al., Boosting heterologous protein production in transgenic dicotyledonous seeds using Phaseolus vulgaris regulatory sequences. Nat. Biotechnol. 2002, 20, 1265-1268.
46. Van Droogenbroeck, B., Cao, J., Stadlmann, J., Altmann, F. et al., Aberrant localization and underglycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds. Proc. Natl. Acad. Sci. USA 2007, 104, 1430-1435.
47. Cox, K. M., Sterling, J. D., Regan, J. T., Gasdaska, J. R. et al., Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat. Biotechnol. 2006, 24, 1591-1597.
48. Koprivova, A., Stemmer, C., Altmann, F., Hoffmann, A. et al., Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol. J. 2004, 2, 517-523.
49. Sourrouille, C., Marquet-Blouin, E., D'Aoust, M. A., Kiefer-Meyer, M. C. et al., Down-regulated expression of plant-specific glycoepitopes in alfalfa. Plant Biotechnol. J. 2008, 6, 702-721.
50. Shin, Y. J., Chong, Y. J., Yang, M. S., Kwon, T. H., Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure. Plant Biotechnol. J. 2011, 9, 1109-1119.
51. Zeitlin, L., Pettitt, J., Scully, C., Bohorova, N. et al., Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proc. Natl. Acad. Sci. USA 2011, 108, 20690-20694.
52. Forthal, D. N., Gach, J. S., Landucci, G., Jez, J. et al., Fc-glycosylation influences Fcgamma receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12. J. Immunol. 2010, 185, 6876-6882.
53. Castilho, A., Gattinger, P., Grass, J., Jez, J. et al., N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology 2011, 21, 813-823.
54. Weise, A., Altmann, F., Rodriguez-Franco, M., Sjoberg, E. R. et al., High-level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella Delta-fuc-t Delta-xyl-t mutant. Plant Biotechnol. J. 2007, 5, 389-401.
55. Parsons, J., Altmann, F., Arrenberg, C. K., Koprivova, A. et al., Moss-based production of asialo-erythropoietin devoid of Lewis A and other plant-typical carbohydrate determinants. Plant Biotechnol. J. 2012, in press. DOI: 10.111/j.1457-7652.2012.00704.x.
56. Jansen, P. L., De Bruijne, J., Controlled-release interferon alpha 2b, a new member of the interferon family for the treatment of chronic hepatitis C. Exp. Opin. Invest. Drugs 2012, 21, 111-118.
57. Taniguchi, N., Korekane, H., Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics. BMB Rep. 2011, 44, 772-781.
58. Okada, T., Ihara, H., Ito, R., Nakano, M. et al., N-Glycosylation engineering of lepidopteran insect cells by the introduction of the beta1, 4-N-acetylglucosaminyltransferase III gene. Glycobiology 2010, 20, 1147-1159.
59. Ferrara, C., Stuart, F., Sondermann, P., Brunker, P., Umana, P., The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. J. Biol. Chem. 2006, 281, 5032-5036.
60. Rouwendal, G. J., Wuhrer, M., Florack, D. E., Koeleman, C. A. et al., Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III. Glycobiology 2007, 17, 334-344.
61. Frey, A. D., Karg, S. R., Kallio, P. T., Expression of rat beta(1, 4)-N-acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation. Plant Biotechnol. J. 2009, 7, 33-48.
62. Karg, S. R., Frey, A. D., Kallio, P. T., Reduction of N-linked xylose and fucose by expression of rat beta1, 4-N-acetylglucosaminyltransferase III in tobacco BY-2 cells depends on Golgi enzyme localization domain and genetic elements used for expression. J. Biotechnol. 2010, 146, 54-65.
63. Nagels, B., Van Damme, E. J., Pabst, M., Callewaert, N., Weterings, K., Production of complex multiantennary N-glycans in Nicotiana benthamiana plants. Plant Physiol. 2011, 155, 1103-1112.
64. Palacpac, N. Q., Yoshida, S., Sakai, H., Kimura, Y. et al., Stable expression of human beta1, 4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Proc. Natl. Acad. Sci. USA 1999, 96, 4692-4697.
65. Bakker, H., Bardor, M., Molthoff, J. W., Gomord, V. et al., Galactose-extended glycans of antibodies produced by transgenic plants. Proc. Natl. Acad. Sci. USA 2001, 98, 2899-2904.
66. Misaki, R., Kimura, Y., Palacpac, N. Q., Yoshida, S. et al., Plant cultured cells expressing human β1, 4-galactosyltransferase secrete glycoproteins with galactose-extended N-linked glycans. Glycobiology 2003, 13, 199-205.
67. Fujiyama, K., Furukawa, A., Katsura, A., Misaki, R. et al., Production of mouse monoclonal antibody with galactose-extended sugar chain by suspension cultured tobacco BY2 cells expressing human beta(1, 4)-galactosyltransferase. Biochem. Biophys. Res. Commun. 2007, 358, 85-91.
68. Bakker, H., Rouwendal, G. J., Karnoup, A. S., Florack, D. E. et al., An antibody produced in tobacco expressing a hybrid beta-1 4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc. Natl. Acad. Sci. USA 2006, 103, 7577-7582.
69. Vézina, L. P., Faye, L., Lerouge, P., D'Aoust, M. A. et al., Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol. J. 2009, 7, 442-455.
70. Strasser, R., Castilho, A., Stadlmann, J., Kunert, R. et al., Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1, 4-galactosylated N-glycan profile. J. Biol. Chem. 2009, 284, 20479-20485.
71. Rouwendal, G. J., Florack, D. E., Hesselink, T., Cordewener, J. H. et al., Synthesis of Lewis X epitopes on plant N-glycans. Carbohydr. Res. 2009, 344, 1487-1493.
72. Wang, J., Zhang, Y., Wei, J., Zhang, X. et al., Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response. Immunology 2007, 121, 174-182.
73. Seveno, M., Bardor, M., Paccalet, T., Gomord, V. et al., Glycoprotein sialylation in plants? Nat. Biotechnol. 2004, 22, 1351-1352.
74. Zeleny, R., Kolarich, D., Strasser, R., Altmann, F., Sialic acid concentrations in plants are in the range of inadvertent contamination. Planta 2006, 224, 222-227.
75. Shah, M. M., Fujiyama, K., Flynn, C. R., Joshi, L., Sialylated endogenous glycoconjugates in plant cells. Nat. Biotechnol. 2003, 21, 1470-1471.
76. Bakker, H., Routier, F., Ashikov, A., Neumann, D. et al., A CMP-sialic acid transporter cloned from Arabidopsis thaliana. Carbohydr. Res. 2008, 343, 2148-2152.
77. Wee, E. G., Sherrier, D. J., Prime, T. A., Dupree, P., Targeting of active sialyltransferase to the plant Golgi apparatus. Plant Cell 1998, 10, 1759-1768.
78. Misaki, R., Fujiyama, K., Seki, T., Expression of human CMP-N-acetylneuraminic acid synthetase and CMP-sialic acid transporter in tobacco suspension-cultured cell. Biochem. Biophys. Res. Commun. 2006, 339, 1184-1189.
79. Castilho, A., Pabst, M., Leonard, R., Veit, C. et al., Construction of a functional CMP-sialic acid biosynthesis pathway in Arabidopsis. Plant Physiol. 2008, 147, 331-339.
80. Castilho, A., Strasser, R., Stadlmann, J., Grass, J. et al., In planta protein sialylation through overexpression of the respective mammalian pathway. J. Biol. Chem. 2010, 285, 15923-15930.
81. Morgan, W. T., Watkins, W. M., Genetic and biochemical aspects of human blood-group A-, B-, H-, Le-a- and Le-b-specificity. Br. Med. Bull 1969, 25, 30-34.
82. Schoberer, J., Strasser, R., Sub-compartmental organization of Golgi-resident N-glycan processing enzymes in plants. Mol. Plant 2011, 4, 220-228.